Skip to main content
About us
Our science
Our Pipeline
Partnering
News & Events
Contact
About us
Our science
Our Pipeline
Partnering
News & Events
Contact
In the news
Press releases
Archive
Jun 10, 2024
Galimedix Therapeutics establishes Scientific Advisory Board of renowned retina experts as company prepares to enter Phase 2 clinical study with GAL-101
Apr 15, 2024
Galimedix is proud to report that the inventor of the company’s groundbreaking technology for the treatment of Alzheimer’s disease and our esteemed co-founder, Prof. Ehud Gazit, has been honored with Germany’s prestigious Meitner-Humboldt Research Award
Mar 8, 2024
Galimedix Therapeutics presents new scientific data showing promising neuroprotective effects of GAL-201 for the treatment of Alzheimer’s disease at AD/PD™ 2024
Upcoming Events
BioJapan 2024
OCTOBER 9-11, 2024
American Academy of Ophthalmology Annual Meeting (AAO)
October 18-21, 2024
BIO-Europe
NOVEMBER 4-6, 2024
International Conference on Dementia and Brain Disorders
NOVEMBER 15-16, 2024
